Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

European Innovation Council · Finished

SUNRISE Tx EIisa –a connected, affordable light solution for treating sleep apnea.

Coordinator
Sunrise, Belgium
Runs
1 July 2022 to 31 December 2024
Status
Finished
EU funding
€1.9m
Total cost
€2.8m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190180051

What the project is doing

In the project's own words, from its summary on CORDIS.

Sunrise is a leading researcher and developer of solutions for diagnosis and treatment of sleep apnea. Our goal is to develop and commercialise Sunrise Tx, the first truly non-invasive, affordable and readily accessible solution to treat sleep apnea. This is to address the 80% treatment gap of sleep apnea sufferers who fail to access treatment due to high costs and long waiting times for diagnosis. Also, even within those diagnosed, at least 35% fail to comply with wearing a mask all night strapped tightly to the face, blowing air to clear airways for breathing due to the associated discomfort.

In contrast Sunrise Tx is a wearable device involving no nasal obstruction. Sunrise Tx is set to improve treatment access, compliance, cost and accuracy.

Topics

Who is involved

OrganisationCityCountryRole
SunriseNamurBelgiumCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI